Advanced search
Publication Cover
Acta Cardiologica Volume 72, 2017 - Issue 4
Submit an article Journal homepage
54
Views
11
CrossRef citations to date
0
Altmetric
Original Articles

Factors associated with severity of sleep apnoea syndrome in patients with chronic kidney disease

Akihito TanakaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, JapanCorrespondence[email protected]
, MD, PhD,
Daijo InagumaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD, PhD,
Eri ItoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD,
Naoki KamegaiKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD,
Akiko KatoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD,
Minami MizutaniKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD,
Hiroya ShimogushiKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD,
Hibiki ShinjoKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD, PhD,
Yasuhiro OtsukaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD, PhD &
Asami TakedaKidney Disease Center, Japanese Red Cross Nagoya Daini Hospital, Nagoya, Japan
, MD, PhD show all
Pages 440-445 | Received 18 May 2016, Accepted 20 Jun 2016, Published online: 14 Jul 2017

REFERENCES

  • Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000; 342: 1378–84.
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005; 365: 1046–53.
  • Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, Bonsignore MR, Grote L, Tkacova R, Lévy P, Riha R, Bassetti C, Narkiewicz K, Mancia G, McNicholas WT; EU COST Action B26 members. Recommendations for the management of patients with obstructive sleep apnoea and hypertension. Eur Respir J 2013; 41: 523–38.
  • Hanly PJ, Ahmed SB. Sleep apnea and the kidney: is sleep apnea a risk factor for chronic kidney disease? Chest 2014; 146: 1114–22.
  • Markou N, Kanakaki M, Myrianthefs P, Hadjiyanakos D, Vlassopoulos D, Damianos A, Siamopoulos K, Vasiliou M, Konstantopoulos S. Sleep-disordered breathing in nondialyzed patients with chronic renal failure. Lung 2006; 184: 43–9.
  • Roumelioti ME, Buysse DJ, Sanders MH, Strollo P, Newman AB, Unruh ML. Sleep-disordered breathing and excessive daytime sleepiness in chronic kidney disease and hemodialysis. Clin J Am Soc Nephrol 2011; 6: 986–94.
  • Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A; Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 2009; 53: 982–92.
  • Sakaguchi Y, Shoji T, Kawabata H, Niihata K, Suzuki A, Kaneko T, Okada N, Isaka Y, Rakugi H, Tsubakihara Y. High prevalence of obstructive sleep apnea and its association with renal function among nondialysis chronic kidney disease patients in Japan: a cross-sectional study. Clin J Am Soc Nephrol 2011; 6: 995–1000.
  • Kasai T, Motwani SS, Elias RM, Gabriel JM, Taranto Montemurro L, Yanagisawa N, Spiller N, Paul N, Bradley TD. Influence of rostral fluid shift on upper airway size and mucosal water content. J Clin Sleep Med 2014; 10: 1069–74.
  • Yumino D, Redolfi S, Ruttanaumpawan P, Su MC, Smith S, Newton GE, Mak S, Bradley TD. Nocturnal rostral fluid shift: a unifying concept for the pathogenesis of obstructive and central sleep apnea in men with heart failure. Circulation 2010; 121: 1598–1605.
  • Adeseun GA, Rosas SE. The impact of obstructive sleep apnea on chronic kidney disease. Curr Hypertens Rep 2010; 12: 378–83.
  • Santos-Silva R, Sartori DE, Truksinas V, Truksinas E, Alonso FF, Tufik S, Bittencourt LR. Validation of a portable monitoring system for the diagnosis of obstructive sleep apnea syndrome. Sleep 2009; 32: 629–36.
  • Manea MM, Comsa M, Minca A, Dragos D, Popa C. Brain-heart axis – Review Article. J Med Life 2015; 8: 266–71.
  • Poggi A, Maggiore Q. Cardiothoracic ratio as a guide to ultrafiltration therapy in dialyzed patients. Int J Artif Organs 1980; 3: 332–7.
  • Silvestry FE, Cohen MS, Armsby LB, Burkule NJ, Fleishman CE, Hijazi ZM, Lang RM, Rome JJ, Wang Y. Guidelines for the Echocardiographic Assessment of Atrial Septal Defect and Patent Foramen Ovale: From the American Society of Echocardiography and Society for Cardiac Angiography and Interventions. J Am Soc Echocardiogr 2015; 28: 910–58.
  • Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39 e14.
  • Wachter R, Lahno R, Haase B, Weber-Kruger M, Seegers J, Edelmann F, Wohlfahrt J, Gelbrich G, Görlitz A, Kermer P, Vollmann D, Hasenfuß G, Gröschel K, Stahrenberg R. Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia–the Find-AF study. PLoS One 2012; 7: e34351.
  • Nakai S, Hanafusa N, Masakane I, Taniguchi M, Hamano T, Shoji T, Hasegawa T, Itami N, Yamagata K, Shinoda T, Kazama JJ, Watanabe Y, Shigematsu T, Marubayashi S, Morita O, Wada A, Hashimoto S, Suzuki K, Nakamoto H, Kimata N, Wakai K, Fujii N, Ogata S, Tsuchida K, Nishi H, Iseki K, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial 2014; 18: 535–602.
  • Tanaka Y, Joki N, Hase H, Iwasaki M, Ikeda M, Ando R, Shinoda T, Inaguma D, Sakaguchi T, Komatsu Y, Koiwa F, Yamaka T, Shigematsu T. Effect of erythropoietin-stimulating agent on uremic inflammation. J Inflamm (Lond) 2012; 9: 17.
  • Kanbay M, Perazella MA, Kasapoglu B, Koroglu M, Covic A. Erythropoiesis stimulatory agent-resistant anemia in dialysis patients: review of causes and management. Blood Purif 2010; 29: 1–12.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
A bold vision to stop cardiovascular disease from being a leading cause of death.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.